Abstract
In the last decade, endocrine therapy strategies in perimenopausal women with hormone-responsive
early breast cancer (BC) have changed and now ovarian function suppression (OFS) is
recommended for the majority of patients. Side effects of OFS mimic menopausal symptoms,
including hot flushes, sweats, weight gain, and sexual dysfunction, which may negatively
impact quality of life (QoL). Aims of the Take Care Project are the education of physicians
and patients to have all the information (medical and nonmedical) they need to manage
menopausal symptoms by distributing educational materials useful to face menopause.
Four different areas have been identified by surveys conducted among physicians and
young patients: for each area, interventions and tools have been elaborated by a doctor
and nonphysician professionals of these identified areas, to offer the widest information
available. Clinical and practical suggestions have been provided. Based on the evidence
given, we strongly suggest setting up a multidisciplinary team for the treatment planning
of young patients with BC, which could help patients to face and manage their new
menopause condition. The reduction of side effects and the improvement in QoL should
be the best ally to treat young patients with BC.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Breast CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Adjuvant systemic treatment of premenopausal women with hormone receptor-positive early breast cancer: lights and shadows.J Clin Oncol Off J Am Soc Clin Oncol. 2019; 37: 862-866
- Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: patient-reported outcomes in the suppression of ovarian function trial.J Clin Oncol Off J Am Soc Clin Oncol. 2016; 34: 1601-1610
- Tailoring adjuvant endocrine therapy for premenopausal breast cancer.N Engl J Med. 2018; 379: 122-137
- Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen.Breast Cancer Res Treat. 2000; 64: 165-176
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.J Clin Oncol Off J Am Soc Clin Oncol. 2016; 34: 611-635
- Diet, nutrition, and cancer: past, present and future.Nat Rev Clin Oncol. 2016; 13: 504-515
- Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013.BMJ. 2016; 354: i3857
- Lifestyle changes as internal medicine.Eur J Intern Med. 2017; 43: e40-e42
- Better population health through behavior change in adults: a call to action.Circulation. 2013; 128: 2169-2176
- Health care 2020: reengineering health care delivery to combat chronic disease.Am J Med. 2015; 128: 337-343
- Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.Circulation. 2005; 112: 1339-1346
- 2018 ESC/ESH Guidelines for the management of arterial hypertension.Eur Heart J. 2018; 39: 3021-3104
- Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials.Ann Intern Med. 2002; 137: 805-813
- The science of obesity management: an endocrine society scientific statement.Endocr Rev. 2018; 39: 79-132
- Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life.Cancer. 1998; 82: 1682-1691
- Risk factors for menopausal hot flashes.Obstet Gynecol. 1994; 84: 29-34
- Effects of the menopause transition and hormone use on cognitive performance in midlife women.Neurology. 2009; 72: 1850-1857
- Psychosocial, behavioral, and health factors related to menopause symptomatology.Womens Health Hillsdale NJ. 1997; 3: 103-120
- Determinants of hot flashes and night sweats.Ann Hum Biol. 2006; 33: 4-16
- The effect of soy consumption on the urinary 2: 16-hydroxyestrone ratio in postmenopausal women depends on equol production status but is not influenced by probiotic consumption.J Nutr. 2005; 135: 603-608
- Insulin resistance and management of the menopause: a clinical hypothesis in practice.Menopause Int. 2011; 17: 24-28
- Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.Maturitas. 2014; 79: 86-90
- Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.Ann Intern Med. 2014; 160: 398-406
- Food consumption and the actual statistics of cardiovascular diseases: an epidemiological comparison of 42 European countries.Food Nutr Res. 2016; 60: 31694
- Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss.Nutr J. 2008; 7: 30
- Low-carb and ketogenic diets in type 1 and type 2 diabetes.Nutrients. 2019; 11: 962
- Is there an optimal diet for weight management and metabolic health?.Gastroenterology. 2017; 152: 1739-1751
- The effects of adjuvant endocrine therapy on bone health in women with breast cancer.J Endocrinol. 2019; 241: R111-R124
- The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer.Eur J Cancer Oxf Engl 1990. 2009; 45: 3205-3212
- Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?.Breast Cancer Res Treat. 2010; 123: 805-814
- Bone health during endocrine therapy for cancer.Lancet Diabetes Endocrinol. 2018; 6: 901-910
- Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.N Engl J Med. 1992; 326: 852-856
- Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.J Clin Oncol Off J Am Soc Clin Oncol. 1996; 14: 78-84
- Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: a cross-sectional study.Bone. 2017; 97: 147-152
- Osteoporosis management in patients with breast cancer: EMAS position statement.Maturitas. 2017; 95: 65-71
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.Lancet. 2015; 386: 433-443
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Oncol. 2019; 20: 339-351
- Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension.J Bone Miner Res. 2018; 33: 190-198
- Antiresorptive agents’ bone-protective and adjuvant effects in postmenopausal women with early breast cancer.Br J Clin Pharmacol. 2019; 85: 1125-1135
- Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.J Clin Endocrinol Metab. 2012; 97: 1871-1880
- Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health.CMAJ Can Med Assoc J. 2017; 189: E268-E274
- Exercise early and often: effects of physical activity and exercise on women's bone health.Int J Environ Res Public Health. 2018; 15: 878
- Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy.Eur J Phys Rehabil Med. 2013; 49: 331-339
- Exercise, osteoporosis, and bone geometry.Sports (Basel). 2017; 5: 29
- Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis.J Sci Med Sport. 2017; 20: 438-445
- Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian.Clin Endocrinol (Oxf). 2018; 89: 280-296
- Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.J Clin Oncol. 2015; 33: 1104-1111
- Aquatic exercise in a chest-high pool for hormone therapy-induced arthralgia in breast cancer survivors: a pragmatic controlled trial.Clin Rehabil. 2013; 27: 123-132
- Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor-associated arthralgia: a feasibility study.J Pain Symptom Manage. 2016; 52: 548-559
- Breast cancer in young women and its impact on reproductive function.Hum Reprod Update. 2009; 15: 323-339
- An update on cancer- and chemotherapy-related cognitive dysfunction: current status.Semin Oncol. 2011; 38: 431-438
- Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.Breast Cancer Res Treat. 2011; 126: 221-226
- Implicit memory varies across the menstrual cycle: estrogen effects in young women.Neuropsychologia. 2002; 40: 518-529
- Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity.Brain Res. 2011; 1379: 188-198
- Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis.Neurodegener Dis. 2010; 7: 163-166
- Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.Neurology. 2014; 82: 222-229
- Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause.Brain J Neurol. 2013; 136: 1432-1445
- Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's.PLoS One. 2013; 8: e59825
- Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.Neurology. 2007; 69: 1074-1083
- Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain.J Natl Cancer Inst Monogr. 2015; 2015: 67-69
- Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.J Clin Oncol. 2012; 30: 3675-3686
- Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.J Clin Oncol. 2012; 30: 2500-2508
- Prefrontal cortex and executive function impairments in primary breast cancer.Arch Neurol. 2011; 68: 1447-1453
- Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.J Clin Oncol. 2010; 28: 1294-1300
- Mirtazapine for the treatment of hot flushes in breast cancer survivors: a prospective pilot trial.Breast J. 2007; 13: 490-495
- Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors.Eur J Cancer Care (Engl). 2018; 27: e12484
- Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.Climacteric J Int Menopause Soc. 2009; 12: 310-318
- A body image scale for use with cancer patients.Eur J Cancer. 2001; 37: 189-197
- Body image in younger breast cancer survivors: a systematic review.Cancer Nurs. 2016; 39: E39-E58
- Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains.Cancer. 2014; 120: 2237-2246
- My changed body: breast cancer, body image, distress and self-compassion.Psychooncology. 2013; 22: 1872-1879
- Supportive and palliative care for patients with chronic mental illness including dementia.Curr Opin Support Palliat Care. 2014; 8: 303-307
Article info
Publication history
Published online: January 31, 2021
Accepted:
January 17,
2021
Received in revised form:
September 29,
2020
Received:
July 26,
2020
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
